You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》雍禾醫療(02279.HK)明起招股 入場費7,979.6元 引入禮來亞洲IDG資本等10基投
阿思達克 11-30 17:19
雍禾醫療(02279.HK)公佈招股詳細,計劃發行9,442.4萬股,當中90%爲國際配售,10%爲香港公開發售。招股價爲每股15.8元,每手500股入場費約7,979.6元。香港公開發售將於明日(12月1日)起至下週一(12月6日)止,預期於12月13日上市。聯席保薦人爲摩根士丹利及中金。 是次IPO將引入10名基石投資者,合共投資9,700萬美元,當中包括開城資本(2,000萬美元)、易方達(1,000萬美元)、IDG資本(1,000萬美元)、Hudson Bay(1,000萬美元)、清池資本(1,000萬美元)、禮來亞洲(1,000萬美元)、WT Capital(1,000萬美元)、常春藤資產管理(700萬美元)、Athos(500萬美元)及York(500萬美元)。基石投資者設6個月禁售期。 集資所得約42.1%將用於爲中國境內網絡現有植髮醫療機構進行擴充和升級;約17.5%將用作投資於產品進一步創新;約9.7%將用作研發投資;約23.4%用作在中國整合行業資源,以提升公司品牌知名度;約1.6%用作結清顯赫植髮應付關聯方新絲域的收購代價之未償還結餘;約5.7%爲營運資金及一般企業用途。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account